TREA

98771029 - BETRUVO

Follow

Information

  • Trademark
  • 98771029
  • Serial Number
    98771029
  • Filing Date
    September 26, 2024
    a year ago
  • Transaction Date
    July 25, 2025
    3 months ago
  • Status Date
    July 24, 2025
    3 months ago
  • Published for Opposition Date
    August 12, 2025
    2 months ago
  • Location Date
    July 24, 2025
    3 months ago
  • Status Code
    681
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    HETZEL, DANNEAN
  • Attorney Name
    Maury M. Tepper, III
    Law Office Assigned Location Code
    L60
  • Owners
Information
Mark Drawing Code
4
Mark Identification
BETRUVO
Case File Statements
  • GS0411: Medical training and teaching
  • GS0051: Pharmaceutical preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations based on morpholino oligomer technology platform for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Pharmaceutical preparations that modulate RNA expression for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Gene therapy products, namely, gene delivery pharmaceuticals; Pharmaceutical preparations for gene therapy, gene editing, and genome editing; Gene therapies in the nature of pharmaceuticals for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Biological preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Viruses, viral vectors and viral constructs for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations, biological preparations and gene therapy products in the nature of pharmaceutical and biological preparations for the treatment of genetic disorders and diseases
  • GS0441: Medical services; providing health information
  • TR0000: The wording BETRUVO has no meaning in a foreign language.
Case File Event Statements
  • 9/26/2024 - a year ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 4/1/2025 - 7 months ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 4/8/2025 - 7 months ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 4/8/2025 - 7 months ago
    6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 7/7/2025 - 4 months ago
    8 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 7/8/2025 - 4 months ago
    12 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 7/8/2025 - 4 months ago
    10 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 7/8/2025 - 4 months ago
    13 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 7/8/2025 - 4 months ago
    11 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 7/8/2025 - 4 months ago
    14 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 7/7/2025 - 4 months ago
    9 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 4/2/2025 - 7 months ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 4/8/2025 - 7 months ago
    5 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 7/7/2025 - 4 months ago
    7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA